Kenneth B. Lee Jr., Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 12,665 shares at $12.69 ($161K) on 2014-03-06, disclosed to the SEC on 2014-03-07.
Open-market sale of $161k BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EYEN | BUY | 2021-06-15 | $33K | — | Filing → |
| BCRX | BUY | 2019-11-18 | $7K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $13K | — | Filing → |